These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 17190857

  • 1. Low-dose versus high-dose therapy for Gaucher disease: Goals and markers.
    Hollak CE, de Fost M, Aerts JM, vom Dahl S.
    Blood; 2007 Jan 01; 109(1):387; author reply 387-8. PubMed ID: 17190857
    [No Abstract] [Full Text] [Related]

  • 2. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
    Tóth J, Szücs FZ, Benkö K, Maródi L.
    Orv Hetil; 2003 Apr 20; 144(16):749-55. PubMed ID: 12778625
    [Abstract] [Full Text] [Related]

  • 3. Seven-year safety and efficacy with velaglucerase alfa for treatment-naïve adult patients with type 1 Gaucher disease.
    Zimran A, Wang N, Ogg C, Crombez E, Cohn GM, Elstein D.
    Am J Hematol; 2015 Jul 20; 90(7):577-83. PubMed ID: 25903392
    [Abstract] [Full Text] [Related]

  • 4. Changes in serum chitotriosidase activity with cessation of replacement enzyme (cerebrosidase) administration in Gaucher disease.
    Czartoryska B, Tylki-Szymańska A, Lugowska A.
    Clin Biochem; 2000 Mar 20; 33(2):147-9. PubMed ID: 10751594
    [No Abstract] [Full Text] [Related]

  • 5. The effect of enzyme therapy in a patient with Gaucher disease type III.
    Bosman DK, Hollak CE, Aerts JM, Bakker HD.
    J Inherit Metab Dis; 1996 Mar 20; 19(5):703-4. PubMed ID: 8892032
    [No Abstract] [Full Text] [Related]

  • 6. Safety and efficacy results of switch from imiglucerase to velaglucerase alfa treatment in patients with type 1 Gaucher disease.
    Elstein D, Mehta A, Hughes DA, Giraldo P, Charrow J, Smith L, Shankar SP, Hangartner TN, Kunes Y, Wang N, Crombez E, Zimran A.
    Am J Hematol; 2015 Jul 20; 90(7):592-7. PubMed ID: 25776130
    [Abstract] [Full Text] [Related]

  • 7. Reduction in imiglucerase dosage causes immediate rise of chitotriosidase activity in patients with Gaucher disease.
    Chien YH, Lee NC, Tsai FJ, Chao MC, Hwu WL.
    Mol Genet Metab; 2010 Sep 20; 101(1):90-1. PubMed ID: 20580583
    [No Abstract] [Full Text] [Related]

  • 8. Bone marrow response in treated patients with Gaucher disease: evaluation by T1-weighted magnetic resonance images and correlation with reduction in liver and spleen volume.
    Terk MR, Dardashti S, Liebman HA.
    Skeletal Radiol; 2000 Oct 20; 29(10):563-71. PubMed ID: 11127678
    [Abstract] [Full Text] [Related]

  • 9. Gaucher disease: hematologic and oncologic implications.
    Hughes D.
    Clin Adv Hematol Oncol; 2011 Oct 20; 9(10):771-2. PubMed ID: 22252578
    [No Abstract] [Full Text] [Related]

  • 10. Dosage-response in the treatment of Gaucher disease by enzyme replacement therapy.
    Beutler E.
    Blood Cells Mol Dis; 2000 Aug 20; 26(4):303-6. PubMed ID: 11042031
    [No Abstract] [Full Text] [Related]

  • 11. Dose-dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher disease.
    Barton NW, Brady RO, Dambrosia JM, Doppelt SH, Hill SC, Holder CA, Mankin HJ, Murray GJ, Zirzow GC, Parker RI.
    J Pediatr; 1992 Feb 20; 120(2 Pt 1):277-80. PubMed ID: 1735829
    [Abstract] [Full Text] [Related]

  • 12. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease.
    Hollak C, Maas M, Akkerman E, den Heeten A, Aerts H.
    Blood Cells Mol Dis; 2001 Feb 20; 27(6):1005-12. PubMed ID: 11831867
    [Abstract] [Full Text] [Related]

  • 13. Different dose-dependent correction of MIP-1beta and chitotriosidase during initial enzyme replacement therapy.
    van Breemen MJ, de Fost M, Maas M, Wiersma MG, Hollak CE, Poll LW, Vom Dahl S, Boot RG, Aerts JM.
    J Inherit Metab Dis; 2009 Apr 20; 32(2):274-9. PubMed ID: 19255873
    [Abstract] [Full Text] [Related]

  • 14. Metaphyseal undertubulation in gaucher disease: resolution at MRI in a patient undergoing enzyme replacement therapy.
    Kelman CG, Disler DG.
    J Comput Assist Tomogr; 2000 Apr 20; 24(1):173-5. PubMed ID: 10667678
    [Abstract] [Full Text] [Related]

  • 15. Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials.
    Hughes DA, Gonzalez DE, Lukina EA, Mehta A, Kabra M, Elstein D, Kisinovsky I, Giraldo P, Bavdekar A, Hangartner TN, Wang N, Crombez E, Zimran A.
    Am J Hematol; 2015 Jul 20; 90(7):584-91. PubMed ID: 25801797
    [Abstract] [Full Text] [Related]

  • 16. Radiology of Gaucher disease (type 1) and bone manifestations: the Dutch experience.
    Maas M, Hollak CE, Akkerman EM, Aerts JF.
    JBR-BTR; 2006 Jul 20; 89(6):318-21. PubMed ID: 17274590
    [Abstract] [Full Text] [Related]

  • 17. The clinical course of treated and untreated Gaucher disease. A study of 45 patients.
    Beutler E, Demina A, Laubscher K, Garver P, Gelbart T, Balicki D, Vaughan L.
    Blood Cells Mol Dis; 1995 Jul 20; 21(2):86-108. PubMed ID: 8846048
    [Abstract] [Full Text] [Related]

  • 18. Effects of imilglucerase withdrawal on an adult with Gaucher disease.
    Schwartz IV, Karam S, Ashton-Prolla P, Michelin K, Coelho J, Pires RF, Pereira ML, Giugliani R.
    Br J Haematol; 2001 Jun 20; 113(4):1089. PubMed ID: 11442517
    [No Abstract] [Full Text] [Related]

  • 19. Low frequency maintenance therapy with imiglucerase in adult type I Gaucher disease: a prospective randomized controlled trial.
    de Fost M, Aerts JM, Groener JE, Maas M, Akkerman EM, Wiersma MG, Hollak CE.
    Haematologica; 2007 Feb 20; 92(2):215-21. PubMed ID: 17296571
    [Abstract] [Full Text] [Related]

  • 20. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results.
    Poll LW, Koch JA, vom Dahl S, Willers R, Scherer A, Boerner D, Niederau C, Häussinger D, Mödder U.
    Skeletal Radiol; 2001 Sep 20; 30(9):496-503. PubMed ID: 11587517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.